rs78038572
Positions:
Variant summary
Our verdict is Benign. Variant got -16 ACMG points: 0P and 16B. BP6_Very_StrongBA1
The NM_014425.5(INVS):c.616-19T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00319 in 1,608,562 control chromosomes in the GnomAD database, including 153 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.017 ( 83 hom., cov: 32)
Exomes 𝑓: 0.0017 ( 70 hom. )
Consequence
INVS
NM_014425.5 intron
NM_014425.5 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: 2.32
Genes affected
INVS (HGNC:17870): (inversin) This gene encodes a protein containing multiple ankyrin domains and two IQ calmodulin-binding domains. The encoded protein may function in renal tubular development and function, and in left-right axis determination. This protein interacts with nephrocystin and infers a connection between primary cilia function and left-right axis determination. A similar protein in mice interacts with calmodulin. Mutations in this gene have been associated with nephronophthisis type 2. Multiple transcript variants encoding distinct isoforms have been identified for this gene. [provided by RefSeq, May 2012]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -16 ACMG points.
BP6
Variant 9-100240041-T-C is Benign according to our data. Variant chr9-100240041-T-C is described in ClinVar as [Likely_benign]. Clinvar id is 260418.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.0587 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
INVS | NM_014425.5 | c.616-19T>C | intron_variant | ENST00000262457.7 | NP_055240.2 | |||
INVS | NM_001318381.2 | c.328-19T>C | intron_variant | NP_001305310.1 | ||||
INVS | NM_001318382.2 | c.-374-19T>C | intron_variant | NP_001305311.1 | ||||
INVS | NR_134606.2 | n.814-19T>C | intron_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
INVS | ENST00000262457.7 | c.616-19T>C | intron_variant | 1 | NM_014425.5 | ENSP00000262457.2 | ||||
INVS | ENST00000262456.6 | c.616-19T>C | intron_variant | 5 | ENSP00000262456.2 | |||||
INVS | ENST00000460636.2 | n.888-19T>C | intron_variant | 5 |
Frequencies
GnomAD3 genomes AF: 0.0173 AC: 2640AN: 152164Hom.: 83 Cov.: 32
GnomAD3 genomes
AF:
AC:
2640
AN:
152164
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00447 AC: 1125AN: 251402Hom.: 25 AF XY: 0.00299 AC XY: 406AN XY: 135866
GnomAD3 exomes
AF:
AC:
1125
AN:
251402
Hom.:
AF XY:
AC XY:
406
AN XY:
135866
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00171 AC: 2496AN: 1456280Hom.: 70 Cov.: 29 AF XY: 0.00143 AC XY: 1036AN XY: 724882
GnomAD4 exome
AF:
AC:
2496
AN:
1456280
Hom.:
Cov.:
29
AF XY:
AC XY:
1036
AN XY:
724882
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0173 AC: 2640AN: 152282Hom.: 83 Cov.: 32 AF XY: 0.0167 AC XY: 1241AN XY: 74470
GnomAD4 genome
AF:
AC:
2640
AN:
152282
Hom.:
Cov.:
32
AF XY:
AC XY:
1241
AN XY:
74470
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
6
AN:
3478
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | clinical testing | GeneDx | Jun 16, 2020 | - - |
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | - | - - |
Nephronophthisis Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 31, 2024 | - - |
Infantile nephronophthisis Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Sep 27, 2021 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
DS_AL_spliceai
Position offset: 19
Find out detailed SpliceAI scores and Pangolin per-transcript scores at